Guidance for industry and FDA staff : early development considerations for innovative combination products

Guidance for industry and FDA staff : early development considerations for innovative combination products.

Other author/creator	United States. Food and Drug Administration. Office of Combination Products.
Format	Electronic and Book
Publication Info	Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Office of the Commissioner, Office of Combination Products, [2006]
Description	13 p. : digital, PDF file
Supplemental Content	https://purl.fdlp.gov/GPO/LPS113681
Subject(s)	Medical instruments and apparatus--Government policy --United States. Drug development--Government policy --United States. Biological products--Government policy --United States.

Portion of title	Early development considerations for innovative combination products
General note	Title from PDF title page (viewed on June 11, 2009).
General note	GPO Cataloging Record Distribution Program (CRDP).
Technical details	Mode of access: Internet at the FDA web site. Address as of 6/11/09: http://www.fda.gov/downloads/RegulatoryInformation/Guidances/ucm126054.pdf ; current access is available via PURL.
GPO item number	0475 (online)
Govt. docs number	HE 20.4002:D 49/2

Library	Location	Call Number	Status	Item Actions
Joyner	Electronic Resources	Access Content Online	✔ Available